307.21
2.31%
-7.28
시간 외 거래:
307.21
전일 마감가:
$314.49
열려 있는:
$312.92
하루 거래량:
512.62K
Relative Volume:
0.93
시가총액:
$22.29B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
41.46
EPS:
7.41
순현금흐름:
$321.60M
1주 성능:
-6.22%
1개월 성능:
+4.74%
6개월 성능:
-13.62%
1년 성능:
-10.37%
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2022-12-14 | 개시 | Deutsche Bank | Hold |
2022-11-30 | 개시 | UBS | Neutral |
2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
2020-10-14 | 개시 | Stephens | Equal-Weight |
2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
2019-04-23 | 개시 | William Blair | Outperform |
2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
2018-01-24 | 개시 | Goldman | Neutral |
2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2017-10-03 | 개시 | Stephens | Equal-Weight |
2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
2016-03-22 | 개시 | Wells Fargo | Outperform |
2010-05-14 | 재확인 | UBS | Neutral |
2010-02-23 | 개시 | Jefferies & Co | Buy |
2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades' - Benzinga
KBC Group NV Sells 7,441 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Zacks Research Issues Negative Forecast for WST Earnings - MarketBeat
West Pharmaceutical Services (NYSE:WST) Expands AI Solutions to Address Profit Challenges and Competition - Yahoo Finance
Mizuho Securities USA LLC Purchases 15,559 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by ING Groep NV - MarketBeat
UBS: West Pharmaceutical Services, Inc. (NYSE:WST) Is A Bottom-Ranked Quant Stock - Insider Monkey
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Drops Amid Sector Downt - GuruFocus.com
Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now? - Simply Wall St
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Sivik Global Healthcare LLC - MarketBeat
Curi RMB Capital LLC Acquires 2,614 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
US pharma company creates 330 jobs in Dublin - Irish Independent
West continues its investment in Ireland with Dublin manufacturing facility expansion - IDA Ireland
Atria Investments Inc Grows Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Chartwell Investment Partners LLC Has $870,000 Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Bought by Principal Financial Group Inc. - MarketBeat
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors - Insider Monkey
West Pharmaceutical Services To Present At UBS Global Healthcare Conference; Webcast At 6:30 PM ET - Nasdaq
North Growth Management Ltd. Has $5.56 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock rises Friday, still underperforms market - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Forte Capital LLC ADV - MarketBeat
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by National Pension Service - MarketBeat
Asset Management One Co. Ltd. Buys 12,745 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock rises Wednesday, still underperforms market - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Pittenger & Anderson Inc. - MarketBeat
West Pharmaceutical Services Inc (WST) Shares Up 3.59% on Nov 5 - GuruFocus.com
Get Ready: West Pharmaceutical Services to Unveil Q3 Financial Results and Insights! - MSN
New York State Common Retirement Fund Decreases Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by New York State Teachers Retirement System - MarketBeat
WST (West Pharmaceutical Services) Revenue : $2,876 Mil (TTM As of Sep. 2024) - GuruFocus.com
International Assets Investment Management LLC Grows Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical's VP Charles Witherspoon sells $218,211 in stock - Investing.com India
West Pharmaceutical Services, Inc. (NYSE:WST) VP Sells $218,211.20 in Stock - MarketBeat
West Pharmaceutical's VP Charles Witherspoon sells $218,211 in stock By Investing.com - Investing.com UK
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Congress Asset Management Co. - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Pharmaceutical Services: Expanding Capacity in High-Value Product Lines & Unlocking Commercial Manufacturing Potential!Major Drivers - Smartkarma
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance - Insider Monkey
AMI Asset Management Corp Has $55.27 Million Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Reports Solid Third-Quarter 2024 Results and Raises Guidance - MSN
West to Participate in Upcoming November 2024 Investor Conferences - BioSpace
West to Participate in Upcoming Investor Conferences - Marketscreener.com
West to Participate in Upcoming Investor Conferences – Company Announcement - Financial Times
On Body Drug Delivery Devices Market: Anticipated Positive - openPR
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility - MSN
Assenagon Asset Management S.A. Acquires 12,769 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
William Blair Has Negative Estimate for WST Q4 Earnings - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):